ATC Group: G02C Other gynecologicals

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G02C in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G02 Other gynecologicals
3 G02C Other gynecologicals

Group G02C contents

Code Title
G02CA Sympathomimetics, labour repressants
G02CB Prolactine inhibitors
G02CC Antiinflammatory products for vaginal administration
G02CX Other gynecologicals

Active ingredients in G02C

Active Ingredient Description
Atosiban

Atosiban is a synthetic peptide which is a competitive antagonist of human oxytocin at receptor level. In human pre-term labour, atosiban at the recommended dosage antagonises uterine contractions and induces uterine quiescence.

Benzydamine

Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis.

Bromocriptine

Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications.

Buphenine
Cabergoline

Cabergoline is a dopaminergic ergoline derivative endowed with a potent and long-lasting PRL-lowering activity.

Fezolinetant

Fezolinetant is a non-hormonal selective neurokinin 3 (NK3) receptor antagonist. It blocks neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron, which is postulated to restore the balance in KNDy neuronal activity in the thermoregulatory centre of the hypothalamus.

Flibanserin

Flibanserin is a multifunctional serotonin agonist and antagonist used for the treatment of premenopausal women with hypoactive sexual desire disorder. In vitro, flibanserin acts as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors. It also has moderate antagonist activities at the 5-HT2B, 5-HT2C, and dopamine D4 receptors.

Ibuprofen

Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.

Lisuride
Naproxen

Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis.

Quinagolide

Quinagolide is a selective dopamine D2-receptor agonist not belonging to the chemical classes of ergot or ergoline compounds. Owing to its dopaminergic action, the drug exerts a strong inhibitory effect on the secretion of the anterior pituitary hormone prolactin, but does not reduce normal levels of other pituitary hormones.

Ritodrine
Terguride

Related product monographs

Title Information Source Document Type  
ADDYI Film coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
BRAMESTON Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
DOSTINEX Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MEDOCRIPTINE Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
NORPROLAC Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PARLODEL Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PIRODAL Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
Tractocile 7.5 mg/ml Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TRACTOCILE Solution for injection European Medicines Agency (EU) MPI, EU: SmPC